1. Haley RW, Marshall WW, McDonald GG, Daugherty MA, Petty F, Fleckenstein JL. Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy. Radiology. 2000;215:807–817. [PubMed] 2. Iversen A, Chalder T, Wessely S. Gulf War Illness: lessons from medically unexplained symptoms. Clin Psychol Rev. 2007;27:842–854. [PubMed] 3. Gronseth GS. Gulf war syndrome: a toxic exposure? A systematic review. Neurol Clin. 2005;23:523–540. [PubMed] 4. Unwin C, Blatchley N, Coke W, Ferry S, Hotopf M, Hull L, Ismail K, Palmer I, David A, Wessely S. Health of UK servicemen who served in Persian Gulf War. Lancet. 1999;353:169–178. [PubMed] 5. Engel CC, Liu X, McCarthy BD, Miller RF, Ursano R. Relationship of physical symptoms to posttraumatic stress disorder among veterans seeking care for gulf war-related health concerns. Psychosom Med. 2000;62:739–745. [PubMed] 6. McDiarmid MA, Keogh JP, Hooper FJ, McPhaul K, Squibb K, Kan R, DiPino R, Anderson L. Health effects of depleted uranium on exposed Gulf War veterans. Environ Res. 2000;82:168–180. [PubMed] 7. Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ. 2000;320:1363–1367. [PMC free article] [PubMed] 8. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med. 1996;2:1382–1385. [PubMed] 9. Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from coexposure to PB, DEET and permethrin: implications of Gulf War chemical exposures. J. Toxicol. Environ. Health. 1996;48:35–56. [PubMed] 10. McCauley LA, Rischitelli G, Lambert WE, Lasarev M, Sticker DL, Spencer PS. Symptoms of Gulf War veterans possibly exposed to organophosphate chemical warfare agents at Khamisiyah, Iraq. Int J Occup Enviro Health. 2001;7:79–89. [PubMed] 11. Wegman DH, Woods NF, Bailar JC. Invited commentary: How would we know a Gulf War syndrome if we saw one? Am J Epidemiol. 1997;146:704–711. [PubMed] 12. Ford JD, Campbell KA, Storzbach D, Binder LM, Anger WK, Rohlman DS. Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf War military service. Psychosom Med. 2001;63:842–849. [PubMed]
13. Binns JH, et al. Research Advisory Committee on Gulf War Veterans' Illnesses. Veterans Administration; 2004. Scientific Progress in Understanding Gulf War Veterans' Illnesses: Report and Recommendations.
14. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl aspartate, creatine and choline. NMR Biomed. 1991;4:47–52. [PubMed] 15. Haley RW, Kurt TL, Hom J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA. 1997;277:215–222. [PubMed] 16. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet. 1996;14:334–336. [PubMed] 17. Haley RW, Billecke S, La Du BN. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol. 1999;157:227–233. [PubMed]
18. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID-I) New York: New York State Psychiatric Institute, Biometrics Research; 1999.
19. Haley RW, Kurt TL, Hom J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA. 1997;277:215–222. [PubMed] 20. Haley RW, Marshal WW, McDonald GG, Daugherty MA, Petty F, Fleckenstein JL. Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy. Radiology. 2000;215:807–817. [PubMed] 21. Hom J, Haley RW, Kurt TL. Neuropsychological correlates of Gulf War syndrome. Arch Clin Neuropsychol. 1997;12:531–544. [PubMed] 22. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a Clinician-Administered PTSD Scale. J. Trauma Stress. 1995;8:75–90. [PubMed] 23. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD Checklist (PCL) Behav Res The. 1996;34:669–673. [PubMed] 24. Keane TM, Caddell JM, Taylor KL. Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: three studies in reliability and validity. J Consult Clin Psychol. 1988;56:85–90. [PubMed] 25. Sobell LC, Sobell MB, Riley DM. The reliability of alcohol abusers' self-reports of drinking and life events that occurred in the distant past. J Stud Alcohol. 1988;49:225–232. [PubMed]
26. Wechsler D. Wechsler Adult Intelligence Scale-III Administration and Scoring Manual. San Antonio: TX: The Psychological Corporation; 1997.
27. Tombaugh TN. Test of Memory Malingering (TOMM) New York, NY: Multi Health Systems; 1994.
28. Conners CK, Staff MHS, editors. Conners’ Continuous Performance Test II: Computer Program for Windows Technical Guide and Software Manual. North Tonwanda, NY: Multi-Health Systems; 2000.
29. Wechsler D. Wechsler Memory Scale. Third Edition ed. San Antonio, TX: The Psychological Corporation; 1997.
30. Benedict R. Brief Visuospatial Memory Test – Revised. Odessa, FL: Professional Manual. Psychological Assessment Resources, Inc.; 1997.
31. Reitan RM. Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271–276.
32. Corrigan JD, Hinkeldey MS. Relationships between parts A and B of the Trail Making Test. J Clin Psychol. 1987;43:402–409. [PubMed] 33. Gaudino EA, Geisler MW, Squires NK. Construct validity in the Trail Making Test: What makes Part B harder? J. Clin. Exp. Neuropsychol. 1995;17:529–535. [PubMed]
34. Delis DC, Kramer JH, Kaplan E, Ober B. The California verbal learning test: Research edition. Research ed. New York: The Psychological Corporation; 1987.
35. Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan Battery Demographic Corrections, Research Findings, and clinical applications. Odessa, FL: Psychological Assessment Resources, Inc.; 1991.
36. Heaton RK, Grant I, Butters N. the HNRC group. The HNRC 500--neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc. 1995;1:231–251. [PubMed]
37. Wilkinson GS. Administration Manual. Delaware: Wide Range Inc.; 1993. Wide Range Achievement Test-III.
38. Wetzel L, Boll TJ. Short Category Test, Booklet Format. Los Angeles, CA: Western Psychological Services; 1987.
39. Benton AB, Hamsher K. Multilingual Aphasia Examination: Word Fluency. Iowa: University of Iowa Department of Neurology and Psychology; 1983.
40. Ruff RM, Light RH, Parker SB, Levin HS. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol. 1996;11:329–338. [PubMed]
41. Reitan RM, Davidson LA. Clinical Neuropsychology: Current Status and Applications. Washington, DC: H. Winston; 1974.
42. Fregly AR, Smith MJ, Graybiel A. Revised normative standards of performance of men on a quantitative ataxia test battery. Acta Otolaryngo. 1973;75:10–16. [PubMed] 43. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. [PubMed]
44. Green BL. Psychometric review of the Trauma History Questionnaire (THQ) In: Stamm BH, editor. Measurement of stress, trauma and adaptation. Lutherville, MD: Sidran Press; 1996.
45. Derogatis L, Lazarus L. SCL-90--R, Brief symptom inventory, and matching clinical rating scales. 217–248. In: Maruish ME, editor. The use of psychological testing for treatment planning and outcome assessment. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.; 1994.
46. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. [PubMed]
47. Kazis LE. The Veterans Sf-36 Health Status Questionnaire: Development and Application in the Veterans Health Administration. The Monitor. The Medical Outcomes Trust. 2000:5.
48. Southwick SM, Morgan A, Nagy LM, Bremner D, Nicolaou AL, Johnson DR, Rosenheck R, Charney DS. Trauma-related symptoms in veterans of Operation Desert Storm: a preliminary report. Am J Psychiatry. 1993;150:1524–1528. [PubMed] 49. Richter RJ, Furlong CE. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics. 1999;9:745–753. [PubMed] 50. Cardenas VA, Studholme C, Meyerhoff DJ, Song E, Weiner MW. Chronic active heavy drinking and family history of problem drinking modulate regional brain tissue volumes. Psychiatry Res. 2005;138:115–130. [PubMed] 51. Soher BJ, Young K, Bernstein A, Aygula Z, Maudsley AA. GAVA: spectral simulation for in vivo MRS applications. J Magn Reson. 2007;185:291–299. [PMC free article] [PubMed] 52. Soher BJ, Pattany PM, Matson GB, Maudsley AA. Observation of coupled 1H metabolite resonances at long TE. Magn Reson Med. 2005;53:1283–1287. [PMC free article] [PubMed] 53. Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med. 1998;40:822–831. [PubMed] 54. Schuff N, Amend D, Knowlton R, Norman D, Fein G, Weiner MW. Age-related metabolite changes and volume loss in hippocampus by proton MR spectroscopic imaging and MRI neurobiology of aging. Neurobiology of Aging. 1999;20:279–285. [PMC free article] [PubMed]
55. McCulloch CE, Searle SR, Neuhaus JM. Generalized, Linear, and Mixed Models. 2nd ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2008.
56. Binns JH, et al. Gulf War Illness and the Health of Gulf War Veterans: Scientific Findings and Recommendations. Washington, DC: Department of Veterans Affairs; 2008.
57. Chao LL, Rothlind JC, Cardenas VA, Meyerhoff DJ, Weiner MW. Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on brain function and brain structure in US veterans. NeuroToxicology. 2010;31:493–501. [PMC free article] [PubMed] 58. Apfel BA, Ross J, Hlavin J, Meyerhoff DJ, Metzler TJ, Marmar CR, Weiner MW, Schuff N, Neylan TC. Hippocampal Volume Differences in Gulf War Veterans with Current versus Lifetime PTSD Symptoms. Submitted to Biological Psychiatry [PMC free article] [PubMed]
59. Ader R. Psychoneuroimmunology. Burlington, MA: Elsevier Academic Press; 2007.
60. Kang HK, Mahan CM, Lee KY, Magee CA, Murphy FM. Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. J. Occup Environ Med. 2000;42:491–501. [PubMed] 61. Roy-Burne P, Smith WR, Goldberg J, Afari N, Buchwald D. Psychol Med. 2004;34:363–368. [PubMed] 62. Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiological studies. Ann N Y Acad Sci. 2004;1032:141–153. [PubMed] 63. Klooker TK, Braak B, Painter RC, de Rooij SR, van Elburg RM, van den Wijngaard RM, Rosebloom TJ, Boeckxstaens GE. Exposure to Severe Wartime Conditions in Early Life is Associated With an Increased Risk of Irritable Bowel Syndrome: A Population-Based Cohort Study. Am J Gastroenterol. 2009 June 9; [Epub ahead of print] [PubMed] 64. Weissbecker I, Floyd A, Dedert E, Slamon P, Sephton S. Childhood Trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology. 2006;3:312–324. [PubMed] 65. Garrison RL, Breeding PP. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med. Hypotheses. 2003;61:182–189. [PubMed] 66. Pall ML. Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum. 2001;32:38–50. [PubMed] 67. Kang HK, Natelson BH, Clare MM, Lee KY, Murphy FM. Post-traumatic stress disorder and chronic fatigue-like illness among Gulf War veterans: A population-based survey or 30,000 veterans. Am J Epidemiol. 2003;157:141–148. [PubMed] 68. Lamproglou I, Barbier L, Diserbo M, Fauvelle F, Fauquette W, Amourette C. Repeated stress in combination with pyridostigmine Part 1: Long-term behavioural consequences. Behav Brain Res. 2009;197:310–310. [PubMed]